Results 21 to 30 of about 715,161 (280)

Full‐house nephropathy in antinuclear antibody‐negative systemic lupus erythematosus: A case report [PDF]

open access: yesClinical Case Reports
Key Clinical Message Antinuclear antibody‐negative full‐house lupus nephritis though previously reported, is fairly uncommon. Some patients go on to develop antibodies later in the disease course.
Reechashree Dhungana   +5 more
doaj   +2 more sources

Significance of antinuclear antibody in Indian patients with rheumatoid arthritis [PDF]

open access: yes, 2022
This study aimed to understand the differences in disease duration, serological parameters, extra Articular Manifestation and treatment of Indian RA patients depending upon antinuclear antibody (ANA) positivity.
Gupta, Rajiva   +4 more
core   +1 more source

Understanding antinuclear antibodies

open access: yesThe Journal of the American Osteopathic Association, 1991
The American College of Rheumatology (formerly the American Rheumatism Association) diagnostic criteria for connective tissue disorders frequently include positive antinuclear antibody (ANA) assays. Proper interpretation of these tests requires an understanding of the principles governing ANA assays.
R M, Pertusi, B R, Rubin
openaire   +2 more sources

Antinuclear Antibodies in Localized Scleroderma [PDF]

open access: yesArthritis & Rheumatism, 1983
AbstractWhen HeLa cells were used as the substrate for detection by the indirect immunofluorescence method, antinuclear antibodies were demonstrated in 16 of 22 (72.7%) sera from patients with localized scleroderma. When mouse kidney sections were used, the positive rate for antinuclear antibodies was 50% (11 of 22).
K, Takehara   +3 more
openaire   +3 more sources

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

open access: yes, 2022
Hepatology, EarlyView.
Robert J. Fontana   +6 more
wiley   +1 more source

Seroconversion to antinuclear antibody negativity and its association with disease flare in patients with systemic lupus erythematosus

open access: yes, 2020
Objective: To evaluate the rate of seroconversion to antinuclear-antibody negativity in patients with systemic lupus erythematosus and its association with subsequent systemic lupus erythematosus flare risk.
권오찬   +6 more
core   +1 more source

Transient expression of antinuclear RNP-A antibodies in patients with acute COVID-19 infection

open access: yesJournal of Translational Autoimmunity, 2022
Introduction: Viral infections have been implicated in the initiation of the autoimmune diseases. Recent reports suggest that a proportion of patients with COVID-19 develop severe disease with multiple organ injuries.
Shuxia Zhou   +4 more
doaj   +1 more source

CYTOMEGALOVIRUS INFECTION AND ITS ANTINUCLEAR ANTIBODY AMONG PATIENTS OF VITILIGO

open access: yes, 2020
Recently, using polymerase chain reaction (PCR) technique, cytomegalovirus DNA has been detected from discolored white spots in patients with vitiligo.
Dr Sadaf Sultan, Dr Faiqa Ijaz, Dr Sohail Ahmad
core   +1 more source

High-Titer Antinuclear Antibody Defines a Distinct IgG4-Related Disease Subset With Predilection for Lung and Kidney Involvement [PDF]

open access: yesJournal of Immunology Research
Jie Zhang   +6 more
doaj   +2 more sources

Antinuclear antibodies in patients with scleroderma. [PDF]

open access: yes, 1982
Antinuclear antibodies were detected in 30 of 38 (79%) patients with scleroderma by indirect immunofluorescence using rat liver sections as a substrate.
Yoshio FURUTA, Furuta, Yoshio
core   +1 more source

Home - About - Disclaimer - Privacy